Title: Hepatocyte-based in vitro model for assessment of drug-induced cholestasis
Authors: Chatterjee, Sagnik
Richert, Lysiane
Augustijns, Patrick
Annaert, Pieter # ×
Issue Date: 2014
Publisher: Academic Press
Series Title: Toxicology and Applied Pharmacology vol:274 issue:1 pages:124-136
Abstract: Early detection of drug-induced cholestasis remains a challenge during drug development.
We have developed and validated a biorelevant sandwich-cultured hepatocytes- (SCH) based model that can identify compounds causing cholestasis by altering bile acid disposition. Human and rat SCH were exposed (24-48 h) to known cholestatic and/or hepatotoxic compounds, in presence or in absence of a concentrated mixture of bile acids (BAs). Urea assay was used to assess (compromised)
hepatocyte functionality at the end of the incubations. The cholestatic potential of the compounds was expressed by calculating a drug-induced cholestasis index (DICI), reflecting the relative residual urea formation by hepatocytes co-incubated with BAs and test compound as compared to hepatocytes treated with test compound alone. Compounds with clinical reports of cholestasis, including cyclosporin A, troglitazone, chlorpromazine, bosentan, ticlopidine, ritonavir, and midecamycin showed enhanced toxicity in the presence of BAs (DICI ≤ 0.8) for at least one of the tested concentrations. In contrast, the in vitro toxicity of compounds causing hepatotoxicity by other mechanisms (including diclofenac, valproic acid, amiodarone and acetaminophen), remained unchanged in the presence of BAs. A safety margin (SM) for drug-induced cholestasis was calculated as the ratio of lowest in vitro concentration for which was DICI ≤ 0.8, to the reported mean peak therapeutic plasma concentration. SM values obtained in human SCH correlated well with reported % incidence of clinical drug-induced cholestasis, while no correlation was observed in rat SCH. This in vitro model enables early identification of drug candidates causing cholestasis by disturbed BA handling.
ISSN: 0041-008X
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Drug Delivery and Disposition
× corresponding author
# (joint) last author

Files in This Item:
File Description Status SizeFormat
Chatterjee_2013_TAAP_postprint version.pdfOA article Published 2418KbAdobe PDFView/Open
2014 - Sagnik - in vitro model for assessment of drug-induced cholestasis - TAP.pdf Published 1339KbAdobe PDFView/Open Request a copy

These files are only available to some KU Leuven Association staff members


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science